Form 4: Thomas Dubin Receives Restricted Shares in Notable Labs, Ltd.

Director Thomas Dubin acquired 40,247 restricted shares in Notable Labs, Ltd. on May 8, 2024, which vest in two equal annual installments.

Summary

• Thomas I. H. Dubin, a director of Notable Labs, Ltd., acquired 40,247 ordinary shares on May 8, 2024.
• The shares were granted as restricted shares and vest in two equal annual installments from the date of grant.
• The transaction was reported on a Form 4 filed with the SEC on May 10, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports a transaction.

Positives

• The grant of restricted shares to a director may align their interests with those of the shareholders.

Future Outlook

The vesting schedule of the restricted shares suggests a commitment from the director for at least two years.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The acquisition of shares by a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates

Keywords

Form 4, restricted shares, beneficial ownership, Notable Labs, Thomas Dubin, director